slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- USD | -.--% |
|
-.--% | -.--% |
Vakgebied
Aantal werknemers: 244
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 26 | 100,0 % | 17 | 100,0 % | -32,42% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 26 | 100,0 % | 17 | 100,0 % | -32,42% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 46 | 01-01-17 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 62 | 24-04-23 |
Sesha Neervannan
COO | Chief Operating Officer | 56 | 16-07-20 |
David Nakasone
IRC | Investor Relations Contact | - | - |
Mark Luz
PRN | Corporate Officer/Principal | - | - |
Scott Youmans
SAM | Sales & Marketing | 53 | 01-03-22 |
Bryan Wahl
LAW | General Counsel | 46 | 19-01-21 |
Maáza Martin
SAM | Sales & Marketing | - | - |
Dianne Whitfield
HRO | Human Resources Officer | 47 | 07-01-21 |
Aziz Mottiwala
PRN | Corporate Officer/Principal | 46 | 01-07-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bill Link
BRD | Director/Board Member | 78 | 01-01-17 |
Wendy Yarno
BRD | Director/Board Member | 68 | 19-11-20 |
Director/Board Member | 69 | 01-12-19 | |
Rosemary Crane
BRD | Director/Board Member | 64 | 11-08-21 |
Bobak Azamian
CEO | Chief Executive Officer | 46 | 01-01-17 |
Andrew Goldberg
BRD | Director/Board Member | 42 | 01-08-20 |
Scott Morrison
BRD | Director/Board Member | 66 | 06-10-22 |
Director/Board Member | 45 | 04-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 37 781 693 | 33 214 163 ( 87,91 %) | 0 | 87,91 % |
Bedrijfsgegevens
![Adres Tarsus Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/124598190.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,55% | 823 mld. | |
+42,31% | 641 mld. | |
-6,83% | 352 mld. | |
+17,15% | 324 mld. | |
+7,09% | 301 mld. | |
+14,02% | 241 mld. | |
+1,64% | 223 mld. | |
+13,66% | 218 mld. | |
+7,87% | 167 mld. |
- Beurs
- Aandelen
- Koers TARS
- Koers
- Onderneming Tarsus Pharmaceuticals, Inc.